FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2534069503> ?p ?o ?g. }

• W2534069503 endingPage "6" @default.
• W2534069503 startingPage "1" @default.
• W2534069503 abstract "Background. Preclinical data indicate that trabectedin followed by irinotecan has strong synergistic effects on Ewing sarcoma. This is presumably due to hypersensitization of the tumor cells to the camptothecin as an effect of trabectedin in addition to synergistic suppression of EWS-FLI1 downstream targets. A strong effect was also reported in a human rhabdomyosarcoma xenograft. Procedure. Twelve patients with end-stage refractory translocation-positive sarcomas were treated with trabectedin followed by irinotecan within a compassionate use program. Eight patients had Ewing sarcoma and four patients had other translocation-positive sarcomas. Results. Three-month survival rate was 0.75 after the start of this therapy. One patient achieved a partial response according to RECIST criteria, five had stable disease, and the remaining six progressed through therapy. The majority of patients experienced significant hematological toxicity (grades 3 and 4). Reversible liver toxicity and diarrhea also occurred. Conclusions. Our experience with the combination of trabectedin followed with irinotecan in patients with advanced sarcomas showed promising results in controlling refractory solid tumors. While the hematological toxicity was significant, it was reversible. Quality of life during therapy was maintained. These observations encourage a larger clinical trial." @default.
• W2534069503 created "2016-10-28" @default.
• W2534069503 creator A5004728115 @default.
• W2534069503 creator A5005540139 @default.
• W2534069503 creator A5010876556 @default.
• W2534069503 creator A5015760028 @default.
• W2534069503 creator A5025105470 @default.
• W2534069503 creator A5027430345 @default.
• W2534069503 creator A5028721392 @default.
• W2534069503 creator A5034557738 @default.
• W2534069503 creator A5045183692 @default.
• W2534069503 creator A5055408774 @default.
• W2534069503 creator A5055703421 @default.
• W2534069503 creator A5057841250 @default.
• W2534069503 date "2016-01-01" @default.
• W2534069503 modified "2023-09-23" @default.
• W2534069503 title "Trabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable Toxicity" @default.
• W2534069503 cites W1974216923 @default.
• W2534069503 cites W1975044418 @default.
• W2534069503 cites W2016454009 @default.
• W2534069503 cites W2069308265 @default.
• W2534069503 cites W2096616470 @default.
• W2534069503 cites W2113996215 @default.
• W2534069503 cites W2127054479 @default.
• W2534069503 cites W2129148702 @default.
• W2534069503 cites W2129834503 @default.
• W2534069503 cites W2142429004 @default.
• W2534069503 cites W2149067734 @default.
• W2534069503 doi "https://doi.org/10.1155/2016/7461783" @default.
• W2534069503 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5098094" @default.
• W2534069503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27843394" @default.
• W2534069503 hasPublicationYear "2016" @default.
• W2534069503 type Work @default.
• W2534069503 sameAs 2534069503 @default.
• W2534069503 citedByCount "15" @default.
• W2534069503 countsByYear W25340695032016 @default.
• W2534069503 countsByYear W25340695032017 @default.
• W2534069503 countsByYear W25340695032018 @default.
• W2534069503 countsByYear W25340695032019 @default.
• W2534069503 countsByYear W25340695032020 @default.
• W2534069503 countsByYear W25340695032021 @default.
• W2534069503 countsByYear W25340695032023 @default.
• W2534069503 crossrefType "journal-article" @default.
• W2534069503 hasAuthorship W2534069503A5004728115 @default.
• W2534069503 hasAuthorship W2534069503A5005540139 @default.
• W2534069503 hasAuthorship W2534069503A5010876556 @default.
• W2534069503 hasAuthorship W2534069503A5015760028 @default.
• W2534069503 hasAuthorship W2534069503A5025105470 @default.
• W2534069503 hasAuthorship W2534069503A5027430345 @default.
• W2534069503 hasAuthorship W2534069503A5028721392 @default.
• W2534069503 hasAuthorship W2534069503A5034557738 @default.
• W2534069503 hasAuthorship W2534069503A5045183692 @default.
• W2534069503 hasAuthorship W2534069503A5055408774 @default.
• W2534069503 hasAuthorship W2534069503A5055703421 @default.
• W2534069503 hasAuthorship W2534069503A5057841250 @default.
• W2534069503 hasBestOaLocation W25340695031 @default.
• W2534069503 hasConcept C121608353 @default.
• W2534069503 hasConcept C126322002 @default.
• W2534069503 hasConcept C141071460 @default.
• W2534069503 hasConcept C142424586 @default.
• W2534069503 hasConcept C142724271 @default.
• W2534069503 hasConcept C143998085 @default.
• W2534069503 hasConcept C2778256501 @default.
• W2534069503 hasConcept C2778629024 @default.
• W2534069503 hasConcept C2780259306 @default.
• W2534069503 hasConcept C2780752271 @default.
• W2534069503 hasConcept C2780844630 @default.
• W2534069503 hasConcept C2908902254 @default.
• W2534069503 hasConcept C29730261 @default.
• W2534069503 hasConcept C526805850 @default.
• W2534069503 hasConcept C535046627 @default.
• W2534069503 hasConcept C71924100 @default.
• W2534069503 hasConcept C86803240 @default.
• W2534069503 hasConcept C87355193 @default.
• W2534069503 hasConcept C90924648 @default.
• W2534069503 hasConceptScore W2534069503C121608353 @default.
• W2534069503 hasConceptScore W2534069503C126322002 @default.
• W2534069503 hasConceptScore W2534069503C141071460 @default.
• W2534069503 hasConceptScore W2534069503C142424586 @default.
• W2534069503 hasConceptScore W2534069503C142724271 @default.
• W2534069503 hasConceptScore W2534069503C143998085 @default.
• W2534069503 hasConceptScore W2534069503C2778256501 @default.
• W2534069503 hasConceptScore W2534069503C2778629024 @default.
• W2534069503 hasConceptScore W2534069503C2780259306 @default.
• W2534069503 hasConceptScore W2534069503C2780752271 @default.
• W2534069503 hasConceptScore W2534069503C2780844630 @default.
• W2534069503 hasConceptScore W2534069503C2908902254 @default.
• W2534069503 hasConceptScore W2534069503C29730261 @default.
• W2534069503 hasConceptScore W2534069503C526805850 @default.
• W2534069503 hasConceptScore W2534069503C535046627 @default.
• W2534069503 hasConceptScore W2534069503C71924100 @default.
• W2534069503 hasConceptScore W2534069503C86803240 @default.
• W2534069503 hasConceptScore W2534069503C87355193 @default.
• W2534069503 hasConceptScore W2534069503C90924648 @default.
• W2534069503 hasLocation W25340695031 @default.
• W2534069503 hasLocation W25340695032 @default.
• W2534069503 hasLocation W25340695033 @default.
• W2534069503 hasLocation W25340695034 @default.

• next